State Licensure Requirements
This activity is designed to satisfy CME/CE state licensure requirements related to Infection Control and Infectious Diseases. Please check with your state licensing board for their specific requirements and print this page as documentation as might be needed. For more information, visit https://www.pri-med.com/state/state-mandated
Faculty
Daniel A. Solomon, MD
Physician, Division of Infectious Diseases, Associate Program Director, MGH/BWH Infectious Diseases Fellowship,
Brigham and Women's Hospital
Assistant Professor of Medicine, Harvard Medical School,
Boston, MA
Learn More
Disclosures
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Daniel A. Solomon, MD: No relevant financial relationships disclosed.
Pamela Kusher, MD (Moderator): Speaker for Janssen, Lilly/BI, AstraZeneca, Bayer, and Novo Nordisk. Advisory for Novo Nordisk, Lilly, Boehringer Ingelheim, AstraZeneca, Abbott, Intuity, Pfizer, and Janssen. Consultant for Lilly, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, and Bayer. Stockholder for Abbott. Speaker for GlaxoSmithKline.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.